SQI Diagnostics Stock Forecast, Price & News

-0.03 (-12.50 %)
(As of 07/26/2021 02:32 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume260,775 shs
Average Volume148,645 shs
Market CapitalizationC$63.44 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SQD News and Ratings via Email

Sign-up to receive the latest news and ratings for SQI Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

About SQI Diagnostics

SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company provides advanced diagnostics targeting organ transplant, autoimmune disease, and serological testing. It also offers TOR-dx, a lung panel test, which enables surgeon to assess the health of donor's lung; and COVID-19 at-home antibody test kit, and the RALI-Dx and RALI-fast point-of care tests to triage COVID-19 patients for respiratory distress. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

SQI Diagnostics (CVE:SQD) Frequently Asked Questions

What stocks does MarketBeat like better than SQI Diagnostics?

Wall Street analysts have given SQI Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SQI Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is SQI Diagnostics' next earnings date?

SQI Diagnostics is scheduled to release its next quarterly earnings announcement on Thursday, August 26th 2021.
View our earnings forecast for SQI Diagnostics

How were SQI Diagnostics' earnings last quarter?

SQI Diagnostics Inc. (CVE:SQD) released its earnings results on Friday, May, 21st. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.32 million for the quarter.
View SQI Diagnostics' earnings history

How has SQI Diagnostics' stock been impacted by Coronavirus?

SQI Diagnostics' stock was trading at C$0.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SQD shares have increased by 133.3% and is now trading at C$0.18.
View which stocks have been most impacted by COVID-19

Who are SQI Diagnostics' key executives?

SQI Diagnostics' management team includes the following people:
  • Dr. Clive J. Beddoe, Chair of the Board of Directors & Interim CEO (Age 74)
  • Mr. Morlan Reddock C.F.A., CPA, CGA, M.B.A., CFO & VP of Admin.
  • Dr. Eric Brouwer, Chief Scientific Officer & Director
  • Dr. Peter Lea Ph.D., Founder (Age 76)
  • Mr. Russell Peloquin, VP of Global Commercial Operations

Who are some of SQI Diagnostics' key competitors?

What other stocks do shareholders of SQI Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include Cigna (CI), Global Payments (GPN), (ALRM), Brookfield Asset Management (BAM.A), Baxter International (BAX), Becton, Dickinson and (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and CytRx (CYTR).

What is SQI Diagnostics' stock symbol?

SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."

How do I buy shares of SQI Diagnostics?

Shares of SQD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is SQI Diagnostics' stock price today?

One share of SQD stock can currently be purchased for approximately C$0.18.

How much money does SQI Diagnostics make?

SQI Diagnostics has a market capitalization of C$63.44 million and generates C$1.03 million in revenue each year.

How many employees does SQI Diagnostics have?

SQI Diagnostics employs 147,000 workers across the globe.

What is SQI Diagnostics' official website?

The official website for SQI Diagnostics is

Where are SQI Diagnostics' headquarters?

SQI Diagnostics is headquartered at 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada.

How can I contact SQI Diagnostics?

SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.